PAREXEL International CorporationNASDAQ
Mon, Sep. 26, 9:55 AM
- PAREXEL (PRXL -0.4%) inks an agreement to buy ExecuPharm for an undisclosed sum. The King of Prussia, PA-based firm provides global functional services to biopharmaceutical companies. The deal should close in the next three weeks.
- Functional services include clinical monitoring, study management, data management, biostatistics, site monitoring, medical writing and pharmacovigilance.